Last reviewed · How we verify
Paliperidone palmitate Treatment B
Paliperidone palmitate Treatment B is a Small molecule drug developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. It is currently in Phase 1 development.
At a glance
| Generic name | Paliperidone palmitate Treatment B |
|---|---|
| Sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Substance Misuse To Psychosis for Stimulants (PHASE2, PHASE3)
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. (PHASE4)
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia (PHASE1)
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants (PHASE1)
- A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia (PHASE1)
- A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia (PHASE1)
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Paliperidone palmitate Treatment B CI brief — competitive landscape report
- Paliperidone palmitate Treatment B updates RSS · CI watch RSS
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. portfolio CI
Frequently asked questions about Paliperidone palmitate Treatment B
What is Paliperidone palmitate Treatment B?
Paliperidone palmitate Treatment B is a Small molecule drug developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
Who makes Paliperidone palmitate Treatment B?
Paliperidone palmitate Treatment B is developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (see full Johnson & Johnson Pharmaceutical Research & Development, L.L.C. pipeline at /company/johnson-johnson-pharmaceutical-research-development-l-l-c).
What development phase is Paliperidone palmitate Treatment B in?
Paliperidone palmitate Treatment B is in Phase 1.